#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Thalassaemia alpha Selective polysaccharide antibody deficiency Head and neck cancer Hodgkin's disease Idiopathic pulmonary fibrosis Acute leukaemia Primitive neuroectodermal tumour Biliary neoplasm Rett syndrome Idiopathic inflammatory myopathy Cardiomyopathy Angiosarcoma metastatic Isodicentric chromosome 15 syndrome Hereditary ataxia Autoimmune demyelinating disease More trials…

    Learn about Rare Diseases

    Congenital hypotransferrinaemia – Life with Disease Haemophilia A with anti factor VIII – Diagnostics Bronchiolitis obliterans syndrome – Treatment Netherton’s syndrome – Diagnostics Mantle cell lymphoma refractory – Trials in Disease Haemophilia B without inhibitors – Diagnostics Factor VIII deficiency – Life with Disease Mucous membrane pemphigoid – Treatment Synovial sarcoma recurrent – Basic Information Cytokine release syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Brexucabtagene Autoleucel Amy109 Pacritinib Dasatinib Cytisinicline Nilutamide Flutafuranol (18F) IMMUNOSTEM Tildacerfont Valine DIMENHYDRINATE Alkaline Phosphatase, Bovine COBALAMIN Brexpiprazole Fumarate Highly Refined Fish Oil Colecalciferol Allo-501A Lepidoglyphus Destructor Mecillinam Cagrilintide More therapies…

    Learn about Your Condition

    Urinary tract infection Tachypnoea Labour induction Proteinuria Astrocytoma malignant Facial paresis End stage renal disease Colorectal adenoma Arginase deficiency Myotonic dystrophy Osteoporosis Osteoarthritis Mesothelioma malignant Vomiting Lumbosacral radiculopathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hypertrophic cardiomyopathy

  • Study on the Effects of Bisoprolol and Verapamil in Patients with Non-Obstructive Hypertrophic Cardiomyopathy

    Recruiting

    3 1 1
    Investigated Diseases:
    • Hypertrophic cardiomyopathy
    Investigated Drugs:
    • Bisoprolol Fumarate
    • Hydrochlorothiazide
    • Verapamil
    Denmark

  • Study of Short‑and Long‑Term Hemodynamic and Physiological Effects of Mavacamten in Patients with Obstructive Hypertrophic Cardiomyopathy

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Hypertrophic cardiomyopathy
    Investigated Drugs:
    • Mavacamten
    Sweden

  • Study on Mavacamten for Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Hypertrophic cardiomyopathy
    Investigated Drugs:
    • Mavacamten
    Austria Belgium Czechia Finland France Germany +5

  • Study on Aficamten for Adults with Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy

    Not recruiting

    3 1
    Investigated Diseases:
    • Hypertrophic cardiomyopathy
    Investigated Drugs:
    • Aficamten
    Denmark France Germany Greece Hungary Iceland +5

  • Study on the Effects of MYK-224 for Patients with Symptomatic Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract Obstruction

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Hypertrophic cardiomyopathy
    Investigated Drugs:
    • Bms-986435
    Italy Poland Spain

  • Study of Mavacamten for Adolescents with Symptomatic Obstructive Hypertrophic Cardiomyopathy

    Not recruiting

    3 1
    Investigated Diseases:
    • Hypertrophic cardiomyopathy
    Investigated Drugs:
    • Mavacamten
    France Germany Ireland Italy Spain
Previous Page
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!